Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP652265.RAUxLib_zDoCq_Zyup6mY9-sC50zhRFqbD3Q9R3dH7mzE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP652265.RAUxLib_zDoCq_Zyup6mY9-sC50zhRFqbD3Q9R3dH7mzE130_assertion type Assertion NP652265.RAUxLib_zDoCq_Zyup6mY9-sC50zhRFqbD3Q9R3dH7mzE130_head.
- NP652265.RAUxLib_zDoCq_Zyup6mY9-sC50zhRFqbD3Q9R3dH7mzE130_assertion description "[Records of 142 patients with chronic hepatitis C (22 with cirrhosis) who had been treated with PEG-IFN and RIB for 24 weeks (Group A, n=88), both drugs for 12-16 weeks (Group B, n=39), or with PEG-IFN for 12-16 weeks and RIB for 24 weeks (Group C, n=15), were analyzed retrospectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652265.RAUxLib_zDoCq_Zyup6mY9-sC50zhRFqbD3Q9R3dH7mzE130_provenance.
- NP652265.RAUxLib_zDoCq_Zyup6mY9-sC50zhRFqbD3Q9R3dH7mzE130_assertion evidence source_evidence_literature NP652265.RAUxLib_zDoCq_Zyup6mY9-sC50zhRFqbD3Q9R3dH7mzE130_provenance.
- NP652265.RAUxLib_zDoCq_Zyup6mY9-sC50zhRFqbD3Q9R3dH7mzE130_assertion SIO_000772 18227568 NP652265.RAUxLib_zDoCq_Zyup6mY9-sC50zhRFqbD3Q9R3dH7mzE130_provenance.
- NP652265.RAUxLib_zDoCq_Zyup6mY9-sC50zhRFqbD3Q9R3dH7mzE130_assertion wasDerivedFrom befree-2016 NP652265.RAUxLib_zDoCq_Zyup6mY9-sC50zhRFqbD3Q9R3dH7mzE130_provenance.
- NP652265.RAUxLib_zDoCq_Zyup6mY9-sC50zhRFqbD3Q9R3dH7mzE130_assertion wasGeneratedBy ECO_0000203 NP652265.RAUxLib_zDoCq_Zyup6mY9-sC50zhRFqbD3Q9R3dH7mzE130_provenance.